EDDIE LABS, INC. – Trademark Portfolio

Entity Type: 03

EDDIE LABS, INC. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include EMPRU and RENEWA. The owner is based in San Diego, CA.

10543 Avenida Olinda Unit 8

San Diego, CA 92127

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IMPULM
IMPULM
Abandoned 2015
REFINA
REFINA
Cancelled 2015
RENEWA
RENEWA
Registered 2015
EMGLU
EMGLU
Cancelled 2015
IMNEU
IMNEU
Cancelled 2015
ENUTRY
ENUTRY
Cancelled 2015
IMCAN
IMCAN
Cancelled 2015
EMPRU
EMPRU
Registered 2015
IMDETOX
IMDETOX
Abandoned 2015
S ALIVE
S ALIVE
Cancelled 2015

Trademark Classifications

EDDIE LABS, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (11 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does EDDIE LABS, INC. have?

EDDIE LABS, INC. has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 6 cancelled.

What trademark classes does EDDIE LABS, INC. file in?

EDDIE LABS, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are EDDIE LABS, INC.'s most well-known trademarks?

EDDIE LABS, INC.'s registered trademark portfolio includes well-known marks such as EMPRU and RENEWA. These are among 2 currently registered trademarks in the portfolio.

What is EDDIE LABS, INC.'s trademark registration success rate?

EDDIE LABS, INC. has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.